Identification of 22 susceptibility loci associated with testicular germ cell tumorsJohn Pluta, Struan F.A. Grant, Louise C. Pyle et al.|Nature Communications|2021Cited by 73
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell CancerJoão Lobo, Robert J. Hamilton, Martin O’Malley et al.|European Urology Oncology|2020Cited by 69
European Association of Urology (EAU) Testicular Cancer Guidelines Panel: A new prognostic factor risk group classification for patients with clinical stage 1 seminoma in active surveillance.Joost L. Boormans, Pilar Laguna, Richard Sylvester et al.|Journal of Clinical Oncology|2023Cited by 4
MicroRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular MassesJulián Chavarriaga, Robert J. Hamilton, Carley Langleben et al.|European Urology Oncology|2025Cited by 2
miRNA as a liquid biomarker to detect malignancy in small testicular massesJ. Chavarriaga, Ruth Hamilton, Carley Langleben et al.|European Urology|2024Cited by 0